CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 120 enrolled
Drug / intervention
Kyphon® Curettedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00810043
NCT00810043Phase 4Completed
CompareCT.gov

Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty

Medtronic Spine LLC·interventional·Posted Dec 17, 2008·Updated Dec 8, 2017

In Brief

A Phase 4 clinical trial evaluating Kyphon® Curette for Vertebral Body Compression Fractures (VCFs). Completed, enrolled 120 participants across 13 sites in 3 countries.

Detailed Summary

The objective of this study is to measure the effect that the scraping and scoring of vertebral cancellous bone using the Kyphon® Curette has on vertebral body anatomy height restoration and angular deformity correction during a balloon kyphoplasty procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVertebral Body Compression Fractures (VCFs)
CountriesBelgium, Germany, United States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 17, 2008
Enrollment StartFeb 1, 2009
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.5 years ago

Interventions

Kyphon® Curettedevice

The Kyphon® Curette is intended to scrape and score bone in the spine. It may be used as an adjunctive device with Kyphon's family of standard access and fracture reduction instruments designed to treat compression fracture during balloon kyphoplasty procedures